2021

1. A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis

   Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2896-2905

2. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

   The Lancet, Vol. 398, Núm. 10315, pp. 1984-1996